Your browser doesn't support javascript.
loading
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells.
Chung, Jiil; Maruvka, Yosef E; Sudhaman, Sumedha; Kelly, Jacalyn; Haradhvala, Nicholas J; Bianchi, Vanessa; Edwards, Melissa; Forster, Victoria J; Nunes, Nuno M; Galati, Melissa A; Komosa, Martin; Deshmukh, Shriya; Cabric, Vanja; Davidson, Scott; Zatzman, Matthew; Light, Nicholas; Hayes, Reid; Brunga, Ledia; Anderson, Nathaniel D; Ho, Ben; Hodel, Karl P; Siddaway, Robert; Morrissy, A Sorana; Bowers, Daniel C; Larouche, Valérie; Bronsema, Annika; Osborn, Michael; Cole, Kristina A; Opocher, Enrico; Mason, Gary; Thomas, Gregory A; George, Ben; Ziegler, David S; Lindhorst, Scott; Vanan, Magimairajan; Yalon-Oren, Michal; Reddy, Alyssa T; Massimino, Maura; Tomboc, Patrick; Van Damme, An; Lossos, Alexander; Durno, Carol; Aronson, Melyssa; Morgenstern, Daniel A; Bouffet, Eric; Huang, Annie; Taylor, Michael D; Villani, Anita; Malkin, David; Hawkins, Cynthia E.
Afiliación
  • Chung J; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Maruvka YE; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Sudhaman S; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kelly J; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts.
  • Haradhvala NJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Bianchi V; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Edwards M; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Forster VJ; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Nunes NM; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Galati MA; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts.
  • Komosa M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Deshmukh S; Harvard Graduate Program in Biophysics, Harvard University, Cambridge, Massachusetts.
  • Cabric V; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Davidson S; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Zatzman M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Light N; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hayes R; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Brunga L; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Anderson ND; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Ho B; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hodel KP; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Siddaway R; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Morrissy AS; Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
  • Bowers DC; The Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
  • Larouche V; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Bronsema A; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Osborn M; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cole KA; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Opocher E; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mason G; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Thomas GA; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • George B; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Ziegler DS; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Lindhorst S; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Vanan M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Yalon-Oren M; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Reddy AT; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Massimino M; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Tomboc P; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Van Damme A; Department of Biochemistry and Molecular Biology, Tulane Cancer Center, Tulane University of Medicine, New Orleans, Louisiana.
  • Lossos A; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Durno C; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Aronson M; Charbonneau Cancer Institute and Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.
  • Morgenstern DA; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Bouffet E; Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, Texas.
  • Huang A; Department of Pediatrics, Centre Mere-enfant Soleil du CHU de Quebec, CRCHU de Quebec, Universite Laval, Quebec City, Quebec, Canada.
  • Taylor MD; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Villani A; Department of Haematology and Oncology, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
  • Malkin D; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hawkins CE; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer Discov ; 11(5): 1176-1191, 2021 05.
Article en En | MEDLINE | ID: mdl-33355208
ABSTRACT
Although replication repair deficiency, either by mismatch repair deficiency (MMRD) and/or loss of DNA polymerase proofreading, can cause hypermutation in cancer, microsatellite instability (MSI) is considered a hallmark of MMRD alone. By genome-wide analysis of tumors with germline and somatic deficiencies in replication repair, we reveal a novel association between loss of polymerase proofreading and MSI, especially when both components are lost. Analysis of indels in microsatellites (MS-indels) identified five distinct signatures (MS-sigs). MMRD MS-sigs are dominated by multibase losses, whereas mutant-polymerase MS-sigs contain primarily single-base gains. MS deletions in MMRD tumors depend on the original size of the MS and converge to a preferred length, providing mechanistic insight. Finally, we demonstrate that MS-sigs can be a powerful clinical tool for managing individuals with germline MMRD and replication repair-deficient cancers, as they can detect the replication repair deficiency in normal cells and predict their response to immunotherapy.

SIGNIFICANCE:

Exome- and genome-wide MSI analysis reveals novel signatures that are uniquely attributed to mismatch repair and DNA polymerase. This provides new mechanistic insight into MS maintenance and can be applied clinically for diagnosis of replication repair deficiency and immunotherapy response prediction.This article is highlighted in the In This Issue feature, p. 995.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / ADN Polimerasa Dirigida por ADN / Inestabilidad de Microsatélites / Reparación de la Incompatibilidad de ADN / Neoplasias Límite: Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / ADN Polimerasa Dirigida por ADN / Inestabilidad de Microsatélites / Reparación de la Incompatibilidad de ADN / Neoplasias Límite: Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: Canadá